mRNA vaccines induce rapid antibody responses in mice

mRNA vaccines induce rapid antibody responses in mice

Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...

Bibliografiset tiedot
Päätekijät:	Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Nature Portfolio 2022-08-01
Sarja:	npj Vaccines
Linkit:	https://doi.org/10.1038/s41541-022-00511-y

Samankaltaisia teoksia

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
Tekijä: Susanne Rauch, et al.
Julkaistu: (2021-04-01)

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
Tekijä: Nicole Roth, et al.
Julkaistu: (2022-08-01)

mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
Tekijä: Charlie Fricke, et al.
Julkaistu: (2024-12-01)

Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
Tekijä: Nicole Roth, et al.
Julkaistu: (2023-01-01)

Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
Tekijä: Björn Corleis, et al.
Julkaistu: (2023-02-01)

mRNA Vaccine Protects against Zika Virus
Tekijä: Lex G. Medina-Magües, et al.
Julkaistu: (2021-12-01)

Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
Tekijä: Shant H. Mahrokhian, et al.
Julkaistu: (2022-02-01)

mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents
Tekijä: Sandro Roier, et al.
Julkaistu: (2023-12-01)

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
Tekijä: Klara Lenart, et al.
Julkaistu: (2022-12-01)

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models
Tekijä: Lex G. Medina-Magües, et al.
Julkaistu: (2023-03-01)

Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses
Tekijä: Hang Chi, et al.
Julkaistu: (2024-03-01)

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Tekijä: Etsuro Nanishi, et al.
Julkaistu: (2022-08-01)

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques
Tekijä: Antonio Valentin, et al.
Julkaistu: (2022-07-01)

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
Tekijä: Shiho Tanaka, et al.
Julkaistu: (2022-02-01)

CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions
Tekijä: Makda Gebre, et al.
Julkaistu: (2018-01-01)

MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies
Tekijä: Janina Haar, et al.
Julkaistu: (2022-06-01)

Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
Tekijä: Hayat Bähr-Mahmud, et al.
Julkaistu: (2023-12-01)

Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals
Tekijä: Sabrina E. Racine-Brzostek, et al.
Julkaistu: (2021-10-01)

Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
Tekijä: Fredrika Hellgren, et al.
Julkaistu: (2023-06-01)

Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies
Tekijä: Nicole Armbruster, et al.
Julkaistu: (2019-09-01)

RETRACTED: Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination
Tekijä: Suzanne M de la Monte, et al.
Julkaistu: (2021-10-01)

mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea
Tekijä: Casey Hensley, et al.
Julkaistu: (2024-03-01)

Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
Tekijä: Cailin E. Deal, et al.
Julkaistu: (2021-01-01)

Engineered mRNA and the Rise of Next-Generation Antibodies
Tekijä: Laura Sanz, et al.
Julkaistu: (2021-09-01)

Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
Tekijä: Fredrika Hellgren, et al.
Julkaistu: (2023-07-01)

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
Tekijä: Zhiyin An, et al.
Julkaistu: (2023-05-01)

How mRNA therapeutics are entering the monoclonal antibody field
Tekijä: Lien Van Hoecke, et al.
Julkaistu: (2019-02-01)

PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART
Tekijä: W. Omange, et al.
Julkaistu: (2022-12-01)

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
Tekijä: Lien Van Hoecke, et al.
Julkaistu: (2020-06-01)

Ekspresi mRNA calprotectin neutrofil penderita rapidly progressive periodontitis
Tekijä: , UTAMI, Trianna Wahyu, et al.
Julkaistu: (2008)

mRNA secondary structures fold sequentially but exchange rapidly in vivo.
Tekijä: Elisabeth M Mahen, et al.
Julkaistu: (2010-02-01)

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters
Tekijä: Bethany Girard, et al.
Julkaistu: (2024-03-01)

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
Tekijä: Puthupparampil V. Scaria, et al.
Julkaistu: (2024-01-01)

Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
Tekijä: Maximiliano L. Cacicedo, et al.
Julkaistu: (2022-10-01)

Intraduodenal Delivery of Exosome-Loaded SARS-CoV-2 RBD mRNA Induces a Neutralizing Antibody Response in Mice
Tekijä: Quan Zhang, et al.
Julkaistu: (2023-03-01)

Toxic Epidermal Necrolysis after COVID-19 mRNA-1237 Vaccination
Tekijä: Nicole Hehr, et al.
Julkaistu: (2023-01-01)

Rapid identification of A29L antibodies based on mRNA immunization and high-throughput single B cell sequencing to detect Monkeypox virus
Tekijä: Huisheng Sun, et al.
Julkaistu: (2024-12-01)

Early Emerging SARS-CoV-2 Spike Mutants Are Diversified in Virologic Properties but Elicit Compromised Antibody Responses
Tekijä: Junhao Fan, et al.
Julkaistu: (2023-12-01)

Rapid Field Immunoassay for Detecting Antibody to Sin Nombre Virus in Deer Mice
Tekijä: Tony Schountz, et al.
Julkaistu: (2007-10-01)

Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
Tekijä: Yuxiang Zhao, et al.
Julkaistu: (2023-10-01)